The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants.

Nat Biotechnol · 2022 · PMC9750863 · PMID 35864170

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

No obvious differences were observed between the two agents; however, a slight trend toward lower viral load in the antibody cocktail group was observed at 5 days p.i.

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.